focus -WSS

focus

author：hotspot 2025-10-01 15:00:05 - browse：9

Humana sign -- health business coverage from STAT — Humana’s Medicare Advantage business is faring even worse than the company let on last week. Ed Reinke/AP

Humana’s Medicare Advantage business is faring even worse than the company let on last week, with “unprecedented” numbers of older adults getting medical care and busting through its tactics for holding up payment.

The country’s second largest private Medicare insurer disclosed Thursday it’s projecting roughly half the profit in 2024 that investors had expected. The news comes a week after Humana already lowered its projected 2023 profit, which still came in at north of $3 billion before taxes.

The stock market’s punishment was swift and decisive, sinking Humana’s share price by roughly 12% at midday. Outgoing CEO Bruce Broussard worked to calm nerves on the company’s investor call, reiterating his confidence in MA. Humana went all-in on the program when it announced last year it would wind down its employer business, but that comes as regulators are beefing up scrutiny of MA plans.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Wikipedia

WSS

Oprah kicked off a national conversation on obesity. Let's have it

Readout LOUD podcast: mifepristone case, GLP

Readout LOUD podcast: mifepristone case, GLP

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Congressmen charge Covid hearing ‘could have been an email’

Commercial surrogacy can be ethical, despite pope’s claims

leisure time

focus

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Time to name cancers by genetics, not organ of origin, expert says

Psychedelics group wrestles with new pharma identity

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Activists slam private health insurers over coverage restrictions

Readout LOUD podcast: mifepristone case, GLP

After affirmative action ruling, medical educators look to 'holistic review'

What we need to know about Arena Bioworks

Supreme Court strikes down use of affirmative action

Do digital therapeutics have a future in medicine?

explore

Quicker fix for pulse oximeters urged during FDA public meeting

Readout Newsletter: Merck, Vertex, and Viking updates

Woodcock on FDA’s accelerated approval and her next chapter

Patient advocates debate FDA's accelerated approval process

Commercial surrogacy can be ethical, despite pope’s claims

Steward Health Care has deal to sell doctor network to UnitedHealth

Wikipedia

focus

knowledge

leisure time